The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: A meta‐analysis
BACKGROUND: The effects of the BRAFV600E mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
[HTML][HTML] Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis
C Liu, T Chen, Z Liu - World journal of surgical oncology, 2016 - Springer
Background The objective of this study is to perform a meta-analysis to evaluate the
associations between the BRAF V600E mutation status and aggressive clinicopathological …
associations between the BRAF V600E mutation status and aggressive clinicopathological …
BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
Abstract Background The BRAF V600E mutation is the most common genetic alteration
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …
[HTML][HTML] Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma
X Wei, X Wang, J Xiong, C Li, Y Liao, Y Zhu… - BioMed Research …, 2022 - hindawi.com
Background. Over the past ten years, the incidence rate of papillary thyroid carcinoma (PTC)
worldwide has been increasing rapidly year by year, with the incidence rate increasing 6 …
worldwide has been increasing rapidly year by year, with the incidence rate increasing 6 …
BRAF V600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis
C Li, KC Lee, EB Schneider… - The Journal of Clinical …, 2012 - academic.oup.com
Background: There is conflicting literature regarding the association of the BRAF V600E
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …
Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid: A meta‐analysis
JH Lee, ES Lee, YS Kim - Cancer, 2007 - Wiley Online Library
BACKGROUND. Numerous studies have investigated the clinical significance of BRAF
mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on …
mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on …
Meta-Analyses of Association Between BRAFV600E Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma
Q Zhang, S Liu, Q Zhang, Y Guan, Q Chen… - Cellular Physiology and …, 2016 - karger.com
Abstract Background/Aims: The function of BRAF V600E as a prognostic biomarker
continues controversial by reason of conflicting results in the published articles. Methods: A …
continues controversial by reason of conflicting results in the published articles. Methods: A …
BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
R Elisei, C Ugolini, D Viola, C Lupi… - The Journal of …, 2008 - academic.oup.com
Background: The BRAFV600E mutation is the most frequent genetic alteration in papillary
thyroid carcinoma (PTC). The role of BRAFV600E mutation as a poor prognostic factor has …
thyroid carcinoma (PTC). The role of BRAFV600E mutation as a poor prognostic factor has …
Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience
C Gouveia, NT Can, A Bostrom… - … –head & neck …, 2013 - jamanetwork.com
Importance Papillary thyroid carcinoma (PTC) is the most common endocrine neoplasm. B-
type raf kinase (BRAF) V600E mutation has been proposed as a negative prognostic …
type raf kinase (BRAF) V600E mutation has been proposed as a negative prognostic …
[HTML][HTML] Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma
C Yan, M Huang, X Li, T Wang… - Endocrine connections, 2019 - ec.bioscientifica.com
Objective To investigate the mutant status of BRAF gene and analyze its relationship to
epidemiological risk factors and clinical outcomes among patients with papillary thyroid …
epidemiological risk factors and clinical outcomes among patients with papillary thyroid …
相关搜索
- thyroid cancer brafv600e mutation
- prognostic factors thyroid cancer
- meta analysis thyroid cancer
- papillary thyroid carcinoma
- thyroid cancer clinicopathological features
- thyroid cancer tumor aggressiveness
- thyroid carcinoma braf v600e
- braf v600e poor outcomes
- outcome of patients thyroid carcinoma
- lack of association braf mutation
- thyroid carcinoma lack of association
- thyroid carcinoma clinical features
- papillary carcinomas clinicopathologic significance
- prognostic factors brafv600e mutation
- prognostic factors poor outcomes
- outcome of patients brafv600e mutation